Skip to content
Healthcare
KZActiveBIN 130640020854
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

ТОО "VIS VITALIS"

Director
Калиманова Индира Рустембековна
Incorporated
26.06.2013
Address
Астана ул. АХМЕТА ЖУБАНОВА, 10А, Н.П. 10
РНН
620300372304

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "VIS VITALIS"
BIN
130640020854
Status
Active
Director
Калиманова Индира Рустембековна
Registration date
26.06.2013
Activity
Прочая деятельность в области здравоохранения, не включенная в другие группировки
Legal address
Астана ул. АХМЕТА ЖУБАНОВА, 10А, Н.П. 10

In government contracts over 2 years

VAT payer
No, deregistered 16.10.2024
КАТО
711410000
РНН
620300372304
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

1
86909primary

Прочая деятельность в области здравоохранения, не включенная в другие группировки

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
277K
2025
474.9K-80%
2024
2.4M+23%
2023
1.9M+27%
2022
1.5M+1787%
2021
80.6K
·277K
2026year to date
-80%474.9K
2025
+23%2.4M
2024
+27%1.9M
2023
+1787%1.5M
2022
·80.6K
2021
2026
Tax paid276,990 ₸
Penalty4,000 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid474,877 ₸
Penalty14,841 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid2,394,368 ₸
Penalty300 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid1,938,776 ₸
Penalty1,766 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid1,521,274 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid80,630 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

4
  • КИ

    Калиманова Индира Рустембековна

    Director

Former directors

  • АЗАБЫЛАЕВА ЗУБАЙДА САЙЛАУОВНА
  • АААКЫБАЕВА АЛМАГУЛЬ УАКИТОВНА
  • ИДИЛЬЯС ДАРИГА СЕНБЕКОВНА
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "VIS VITALIS" (BIN 130640020854) is an active legal entity in Астана, registered in 2013 (13 years on the market). Primary activity — прочая деятельность в области здравоохранения, не включенная в другие группировки. Per open government registries as of November 6, 2026: 34 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 38,330,774 ₸. Automated screening of open registries found no risk indicators for "VIS VITALIS". Director on record — Калиманова Индира Рустембековна. Data current as of November 6, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.